TRIM56 has a restrictive role in the replication of RNA viruses like HCoV-OC43, so it is likely that TRIM56 similarly interacts with SARS-CoV-2 and as a result, the reduction of TRIM56 observed in patients with severe COVID-19 may be associated with the superior viral load in these patients. This evidence concerns the gene TRIM56 and COVID-19.